IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma.
Patient Resources
Information on sarcoma subtypes, treatments, clinical trials, and other important resources for sarcoma patients and families.
Sarcoma Patient Registry
Information on the Sarcoma Patient Registry. If you are diagnosed with sarcoma, please consider joining the Registry.
Research Grants
Information on applying for a sarcoma research grant, current research funded by the SFA, and past research grants.